大塚化学 Official site

Notice of Hybrid Seminar on April 26, 2024 (Friday)

The forefront of mid-sized molecular medicine! The latest research and technologies in fluorination, flow synthesis, and computational science are the themes.

We are pleased to announce that on April 26 (Friday), we will be co-hosting a free hybrid seminar titled "The Cutting Edge of Mid-Molecule Pharmaceuticals - Latest Research and Technologies in Fluorination, Flow Synthesis, and Computational Science" in collaboration with Otsuka Chemical and Syncrest. On the day of the event, there will be presentations from Ryukyu University, Nagoya University, and Syncrest Corporation, followed by a Q&A session. We sincerely look forward to the participation of many of you. This seminar is a must-attend for those interested in organic chemical synthesis research and its implementation technologies aimed at drug discovery. 【Seminar Overview】 ■ Date and Time: April 26, 2024 (Friday) from 14:00 to 15:50 (scheduled to end) * Networking event & lab tour: 16:00 to 17:00 (scheduled to end) ■ Theme: "The Cutting Edge of Mid-Molecule Pharmaceuticals - Latest Research and Technologies in Fluorination, Flow Synthesis, and Computational Science" ■ Participation Fee: Free ■ Format: In-person (Shonan i-Park), WEB (Zoom) *For more details, please refer to the related links or feel free to contact us.

Related Link - https://info.otsukac.co.jp/public/seminar/view/661

basic information

【Other Seminar Overview】 ■ Program - Professor Akira Arimitsu, Department of Marine Natural Sciences, Faculty of Science, University of the Ryukyus "Development and Synthetic Applications of Selective Fluorination Reactions Using Organic Catalysts" (30 minutes) - Hiroshi Murayama, Senior Manager, Syncrest Corporation "Inline Sensing Technology to Enhance Transparency in Chemical Processes and Its Applications" (15 minutes) - Professor Masahiro Higashi, Graduate School of Mathematics, Nagoya University "Mechanistic Elucidation of Organic Reactions through Theoretical Calculations" (30 minutes) - Pengyu Xu, CEO, Syncrest Corporation "The Fusion of Computational Science, Flow Synthesis, and Organic Synthesis from the Perspective of Drug Discovery Support" (15 minutes) *For more details, please refer to the related links or feel free to contact us.

Price range

Delivery Time

Applications/Examples of results

For more details, please refer to the related links or feel free to contact us.

Distributors

Recommended products